SLNO

SLNO Other Income/Expenses (Net)

$11.80MTTM · USD

Period ending:

SLNO FY Other Income/Expenses (Net)USD
SLNO FY Other Income/Expenses (Net)2012-12-31: -$2.88M2013-12-31: -$2.86M2014-12-31: -$8.08M2015-12-31: -$3.75M2016-12-31: $1.59M2017-12-31: -$1.27M2018-12-31: $2.46M2019-12-31: -$7.58M2020-12-31: $7.31M2021-12-31: $618.00K2022-12-31: $330.00K2023-12-31: $2.40M2024-12-31: $11.82M2025-12-31: $5.94M$11.82M-$8.08M
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SLNO other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Soleno Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
5,940,000
11,821,000
2,396,000
330,000
618,000
7,310,000
-7,577,000
2,460,000
-1,271,000
1,586,497
-3,748,800
-8,077,887
-2,860,460
-2,884,778

Compare other income/expenses (net)

All SLNO financial metrics · SLNO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.